SCHEMBL3636352

SCHEMBL3636352

O=C(OCCCN(Cc1ccccc1)Cc1ccccc1)N1CCC(Nc2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 3/20 0.46
KDM4E B2RXH2 3/20 0.46
RORC P51449 2/20 0.46
GAA P10253 1/20 0.46
MCL1 Q07820 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NOS2 P35228 1/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TSHR P16473 1/20 0.43
GRIN2B Q13224 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13079367 0.93 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL13079560 0.84 KDM4E (0.48) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL3639488 0.81 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL13079883 0.80 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL924781 0.80 SMN1; SMN2 (0.67) MEN1KMT2ALMNAKDM4ENOS2
SCHEMBL3636241 0.77 RORC (0.49) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL3636237 0.77 RORC (0.49) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL3754340 0.77 MEN1 (0.46) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL3754339 0.77 MEN1 (0.46) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL3754332 0.77 MEN1 (0.46) ALDH1A1MEN1KMT2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 WO disclosed